On the public citation graph
NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIES
0 signed · 1257 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4645306openalex-extracted
Action Mechanisms of Donepezil in Cardiac and Vascular Aspects: A Review
inferred← citeshttps://doi.org/10.1001/archneur.1979.00500440071014openalex-snapshot
Effect of Physostigmine on Constructional and Memory Tasks in Alzheimer's Disease
inferred← citeshttps://doi.org/10.1001/archneur.1983.04210070067022openalex-snapshot
Lethicin in the Treatment of Alzheimer's Disease
inferred← citeshttps://doi.org/10.1001/archneur.1984.04210080010005openalex-snapshot
-Aminobutyric Acid and Homovanillic Acid Concentration in the CSF of Patients With Senile Dementia of Alzheimer's Type
inferred← citeshttps://doi.org/10.1001/archneur.1985.04060050091016openalex-snapshot
CSF Monoamine Metabolite Levels in Alzheimer's and Parkinson's Disease
inferred← citeshttps://doi.org/10.1001/archneur.1986.00520050094034openalex-snapshot
Dementia With Cerebral Lewy Bodies
inferred← citeshttps://doi.org/10.1001/archneur.1986.00520070017009openalex-snapshot
Muscarinic Agonist Therapy of Alzheimer's Disease
inferred← citeshttps://doi.org/10.1001/archneur.1987.00520160031010openalex-snapshot
Neuropsychiatric Aspects of Multi-infarct Dementia and Dementia of the Alzheimer Type
inferred← citeshttps://doi.org/10.1001/archneur.1988.00520310028012openalex-snapshot
Reductions in Acetylcholine and Nicotine Binding in Several Degenerative Diseases
inferred← citeshttps://doi.org/10.1001/archneur.1988.00520320022009openalex-snapshot
Reduced Activities of Thiamine-Dependent Enzymes in the Brains and Peripheral Tissues of Patients With Alzheimer's Disease
inferred← citeshttps://doi.org/10.1001/archneur.1995.00540350081020openalex-snapshot
Cognitive Test Performance in Detecting, Staging, and Tracking Alzheimer's Disease
inferred← citeshttps://doi.org/10.1001/archneur.60.12.1745openalex-snapshot
Cortical Cholinergic Function Is More Severely Affected in Parkinsonian Dementia Than in Alzheimer Disease
inferred← citeshttps://doi.org/10.1001/jama.281.15.1433openalex-snapshot
Challenging the Cholinergic Hypothesis in Alzheimer Disease
inferred← citeshttps://doi.org/10.1002/(sici)1096-9861(19961028)374:4<555::aid-cne6>3.0.co;2-0openalex-snapshot
Direct catecholaminergic-cholinergic interactions in the basal forebrain. II. Substantia nigra-ventral tegmental area projections to cholinergic neurons
inferred← citeshttps://doi.org/10.1002/(sici)1096-9861(19990322)405:4<491::aid-cne4>3.0.co;2-nopenalex-snapshot
Evidence that nerve growth factor influences recent memory through structural changes in septohippocampal cholinergic neurons
inferred← citeshttps://doi.org/10.1002/(sici)1097-4547(19990115)55:2<178::aid-jnr5>3.0.co;2-uopenalex-snapshot
Septohippocampal adaptive GABAergic responses by AF64A treatment
inferred← citeshttps://doi.org/10.1002/(sici)1098-2396(199704)25:4<368::aid-syn8>3.0.co;2-8openalex-snapshot
Imaging of cholinergic terminals using the radiotracer [18F](+)-4-fluorobenzyltrozamicol: In vitro binding studies and positron emission tomography studies in nonhuman primates
inferred← citeshttps://doi.org/10.1002/(sici)1099-1166(199701)12:1<7::aid-gps484>3.0.co;2-popenalex-snapshot
Alzheimer?s Disease in Senile Dementia: Loss of Neurones in the Basal Forebrain. Whitehouse, P., Price, D., Struble, R., Clarke, A., Coyle, J. and Delong, M.Science (1982), 215, 1237-1239
inferred← citeshttps://doi.org/10.1002/(sici)1099-1166(200003)15:3<242::aid-gps110>3.0.co;2-7openalex-snapshot
Lack of adverse pharmacodynamic drug interactions with rivastigmine and twenty-two classes of medications
inferred← citeshttps://doi.org/10.1002/14651858.cd004395openalex-snapshot
Donepezil for vascular cognitive impairment
inferred← citeshttps://doi.org/10.1002/14651858.cd004395.pub2openalex-snapshot
Donepezil for vascular cognitive impairment
inferred← citeshttps://doi.org/10.1002/14651858.cd008782openalex-snapshot
Plasma and Cerebro Spinal Fluid Amyloid Beta 42, 40 and the 42:40 ratio for diagnosis of incipient Dementia in a population with objective cognitive decline.
inferred← citeshttps://doi.org/10.1002/14651858.cd008782.pub2openalex-snapshot
Plasma and Cerebro Spinal Fluid Amyloid Beta 42, 40 and the 42:40 ratio for diagnosis of incipient Dementia in a population with objective cognitive decline.
inferred← citeshttps://doi.org/10.1002/14651858.cd008782.pub3openalex-snapshot
Plasma and CSF Abeta for the longitudinal prediction of Alzheimer's disease dementia and other dementias in people with cognitive decline but no dementia
inferred← citeshttps://doi.org/10.1002/9780470669600.ch50openalex-snapshot
Neurochemistry of Alzheimer's Disease
inferred← citeshttps://doi.org/10.1002/9780470682531.pat0134openalex-snapshot
Syntheses and Uses of Isotopically Labelled Compounds Containing C C , C O or C N Groups
inferred← citeshttps://doi.org/10.1002/9781118753378.ch109openalex-snapshot
Cognitive Enhancers and Treatments for Alzheimer's Disease
inferred← citeshttps://doi.org/10.1002/9781118772034.ch21openalex-snapshot
Alzheimer's Disease and Mild Cognitive Impairment
inferred← citeshttps://doi.org/10.1002/ajp.1350110210openalex-snapshot
Choline acetyltransferase and acetylcholinesterase activities in neocortex and hippocampus of squirrel monkey (Saimiri sciureus)
inferred← citeshttps://doi.org/10.1002/alz.12229openalex-snapshot
Nerve growth factor (NGF) pathway biomarkers in Down syndrome prior to and after the onset of clinical Alzheimer's disease: A paired CSF and plasma study
inferred← citeshttps://doi.org/10.1002/alz.12999openalex-snapshot
Basal forebrain atrophy along the Alzheimer's disease continuum in adults with Down syndrome
inferred← citeshttps://doi.org/10.1002/alz.70445openalex-snapshot
Single‐nucleus analysis reveals oxidative stress in Down syndrome basal forebrain neurons at birth
inferred← citeshttps://doi.org/10.1002/alz.71694openalex-snapshot
Perspectives from Alzheimer's Disease Research Centers site directors on the early steps and the lasting impact
inferred← citeshttps://doi.org/10.1002/ana.20100openalex-snapshot
Cholinergic nucleus basalis tauopathy emerges early in the aging‐MCI‐AD continuum
inferred← citeshttps://doi.org/10.1002/ana.23874openalex-snapshot
Cholinergic enhancement of functional networks in older adults with mild cognitive impairment
inferred← citeshttps://doi.org/10.1002/ana.410070503openalex-snapshot
The relationships of aging changes in the basal ganglia to manifestations of Huntington's chorea
inferred← citeshttps://doi.org/10.1002/ana.410070517openalex-snapshot
Central cholinergic activity in aluminum‐induced neurofibrillary degeneration
inferred← citeshttps://doi.org/10.1002/ana.410100410openalex-snapshot
Regional activities of metabolic enzymes and glutamate decarboxylase in human brain
inferred← citeshttps://doi.org/10.1002/ana.410120504openalex-snapshot
Cerebral metabolism and atrophy in huntington's disease determined by 18FDG and computed tomographic scan
inferred← citeshttps://doi.org/10.1002/ana.410130116openalex-snapshot
Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain
inferred← citeshttps://doi.org/10.1002/ana.410140306openalex-snapshot
Alzheimer's disease: Choline acetyltransferase activity in brain tissue from clinical and pathological subgroups
inferred← citeshttps://doi.org/10.1002/ana.410150723openalex-snapshot
Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease
inferred← citeshttps://doi.org/10.1002/ana.410180503openalex-snapshot
Dopaminergic and cholinergic lesions in progressive supranuclear palsy
inferred← citeshttps://doi.org/10.1002/ana.410190206openalex-snapshot
Systematic regional differences in the cholinergic innervation of the primate cerebral cortex: Distribution of enzyme activities and some behavioral implications
inferred← citeshttps://doi.org/10.1002/ana.410190307openalex-snapshot
Regional distribution of amino acid transmitters in postmortem brains of presenile and senile dementia of Alzheimer type
inferred← citeshttps://doi.org/10.1002/ana.410200303openalex-snapshot
Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease
inferred← citeshttps://doi.org/10.1002/ana.410200407openalex-snapshot
Neurofibrillary degeneration of cholinergic and noncholinergic neurons of the basal forebrain in Alzheimer's disease
inferred← citeshttps://doi.org/10.1002/ana.410200408openalex-snapshot
Widespread reduction of somatostatin‐like immunoreactivity in the cerebral cortex in Alzheimer's disease
inferred← citeshttps://doi.org/10.1002/ana.410200603openalex-snapshot
Vasopressin in Alzheimer's disease: A study of postmortem brain concentrations
inferred← citeshttps://doi.org/10.1002/ana.410220207openalex-snapshot
Aminergic systems in Alzheimer's disease and Parkinson's disease
inferred← citeshttps://doi.org/10.1002/ana.410220412openalex-snapshot
Alzheimer‐related neuronal protein A68: Specificity and distribution
inferred← citeshttps://doi.org/10.1002/ana.410280207openalex-snapshot
Galanin immunoreactivity is increased in the nucleus basalis of meynert in Alzheimer's disease
inferred← citeshttps://doi.org/10.1002/ana.410400309openalex-snapshot
In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease
inferred← citeshttps://doi.org/10.1002/ardp.201500117openalex-snapshot
Multiple Ligands Targeting Cholinesterases and β‐Amyloid: Synthesis, Biological Evaluation of Heterodimeric Compounds with Benzylamine Pharmacophore
inferred← citeshttps://doi.org/10.1002/bms.1200220703openalex-snapshot
Determination of an acetylcholinesterase inhibitor, MDL 73745, in dog plasma and urine by combined gas chromatography/negative ion chemical ionization mass spectrometry
inferred← citeshttps://doi.org/10.1002/cmdc.202100265openalex-snapshot
Homarine Alkyl Ester Derivatives as Promising Acetylcholinesterase Inhibitors
inferred← citeshttps://doi.org/10.1002/cne.10737openalex-snapshot
Cholinergic neuropathology in a mouse model of Alzheimer's disease
inferred← citeshttps://doi.org/10.1002/cne.20833openalex-snapshot
Basal forebrain cholinergic system of the anuran amphibian Rana perezi: Evidence for a shared organization pattern with amniotes
inferred← citeshttps://doi.org/10.1002/cne.902260208openalex-snapshot
Acetylcholinesterase‐immunoreactive axonal network in monkey visual cortex
inferred← citeshttps://doi.org/10.1002/cne.902380404openalex-snapshot
II. Cortical neurons immunoreactive with antisera against neuropeptide Y are altered in Alzheimer's‐type dementia
inferred← citeshttps://doi.org/10.1002/cne.902480307openalex-snapshot
Distribution of altered hippocampal neurons and axons immunoreactive with antisera against neuropeptide Y in Alzheimer's‐type dementia
inferred← citeshttps://doi.org/10.1002/cne.902500206openalex-snapshot
Ultrastructural organization of choline acetyltransferase‐immunoreactive fibres innervating the neocortex from embryonic ventral forebrain grafts
inferred← citeshttps://doi.org/10.1002/cne.902600205openalex-snapshot
Somatostatin immunoreactive neurons in the human hippocampus and cortex shown by immunogold/silver intensification on vibratome sections: Coexistence with neuropeptide Y neurons, and effects alzheimer‐type dementia
inferred← citeshttps://doi.org/10.1002/cne.902770304openalex-snapshot
Basal forebrain efferents to the medial dorsal thalamic nucleus in the rhesus monkey
inferred← citeshttps://doi.org/10.1002/cne.903030110openalex-snapshot
Galanin mRNA in the nucleus basalis of Meynert complex of baboons and humans
inferred← citeshttps://doi.org/10.1002/cne.903430206openalex-snapshot
Highly selective effects of nerve growth factor, brain‐derived neurotrophic factor, and neurotrophin‐3 on intact and injured basal forebrain magnocellular neurons
inferred← citeshttps://doi.org/10.1002/cne.903480304openalex-snapshot
Ultrastructural and morphometric features of the acetylcholine innervation in adult rat parietal cortex: An electron microscopic study in serial sections
inferred← citeshttps://doi.org/10.1002/ctm2.397openalex-snapshot
Alzheimer's disease: An evolving understanding of noradrenergic involvement and the promising future of electroceutical therapies
inferred← citeshttps://doi.org/10.1002/ddr.10086openalex-snapshot
Preclinical experiments on cognition enhancement in Alzheimer's disease: Drugs affecting nicotinic acetylcholine receptors
inferred← citeshttps://doi.org/10.1002/ddr.430020508openalex-snapshot
Piracetam in the treatment of cognitive impairment in the elderly
inferred← citeshttps://doi.org/10.1002/ddr.430050106openalex-snapshot
Neuropathological processes in Alzheimer's disease
inferred← citeshttps://doi.org/10.1002/ddr.430050107openalex-snapshot
Is it possible to design rational treatments for the symptoms of Alzheimer's disease?
inferred← citeshttps://doi.org/10.1002/ddr.430120310openalex-snapshot
Cognitive functions affected by scopolamine in alzheimer's disease and normal aging
inferred← citeshttps://doi.org/10.1002/ddr.430140202openalex-snapshot
Cholinergic systems and alzheimer's disease
inferred← citeshttps://doi.org/10.1002/fsn3.71631openalex-snapshot
Relationship Between Dietary Choline Intake and Cognitive Function in the United States: A Cross‐Sectional Study of the 2011–2014 NHANES Cycle
inferred← citeshttps://doi.org/10.1002/gps.930050508openalex-snapshot
Tetrahydroaminoacridine in Alzheimer's disease
inferred← citeshttps://doi.org/10.1002/gps.930070306openalex-snapshot
The role of two major cholinergic systems in memory acquistion and retention in the eight‐arm radial maze
inferred← citeshttps://doi.org/10.1002/gps.936openalex-snapshot
Have cholinergic therapies reached their clinical boundary in Alzheimer's disease?
inferred← citeshttps://doi.org/10.1002/hup.470060205openalex-snapshot
Tetrahydroaminoacridine in Alzheimer's dementia: Clinical and biochemical results of a double‐blind crossover trial
inferred← citeshttps://doi.org/10.1002/j.1552-4604.1989.tb03328.xopenalex-snapshot
Single Dose Safety, Tolerance, and Pharmacokinetics of HP 029 in Healthy Young Men: A Potential Alzheimer Agent
inferred← citeshttps://doi.org/10.1002/j.1552-4604.1990.tb03576.xopenalex-snapshot
Multiple Dose Pharmacokinetics, Safety, and Tolerance of Velnacrine (HP 029) in Healthy Elderly Subjects: A Potential Therapeutic Agent for Alzheimer's Disease
inferred← citeshttps://doi.org/10.1002/j.2040-4603.1994.tb01684.xopenalex-snapshot
Human Nervous System
inferred← citeshttps://doi.org/10.1002/jccs.199400035openalex-snapshot
Electrochemical Oxidations of Central Nervous System Indoleamines, Catecholamines and Alkaloids: Potential Significance into Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.1002/jhet.5570440305openalex-snapshot
Synthesis of tacrine derivatives under solventless conditions
inferred← citeshttps://doi.org/10.1002/jlcr.2580310707openalex-snapshot
14C‐labeling of a tetrahydroacridine, a novel CNS‐selective cholinesterase inhibitor
inferred← citeshttps://doi.org/10.1002/jlcr.2580400201openalex-snapshot
XIIth international symposium on radiopharmaceutical chemistry: Abstracts and programme
inferred← citeshttps://doi.org/10.1002/jnr.490080403openalex-snapshot
Biochemical development of the human brain. III. Benzodiazepine receptors, free Y‐aminobutyrate (GABA) and other amino acids
inferred← citeshttps://doi.org/10.1002/jnr.490270419openalex-snapshot
Neurotransmitter changes in alzheimer's disease: Implications to diagnostics and therapy
inferred← citeshttps://doi.org/10.1002/mabi.202400658openalex-snapshot
Magnetic Levitational Assembly of Differentiated SH‐SY5Y Cells for Aβ‐Induced 3D Alzheimer's Disease Modeling and Curcumin Screening
inferred← citeshttps://doi.org/10.1002/mds.870040107openalex-snapshot
Reduced glutamate decarboxylase activity in the subthalamic nucleus in patients with tardive dyskinesia
inferred← citeshttps://doi.org/10.1002/med.2610030302openalex-snapshot
The neurochemistry of Alzheimer's disease and senile dementia
inferred← citeshttps://doi.org/10.1002/med.2610030303openalex-snapshot
Neuropharmacology of degenerative diseases associated with aging
inferred← citeshttps://doi.org/10.1002/med.70047openalex-snapshot
Multi‐Targeting Ligands as Prospective Therapeutics for Alzheimer's Disease, a Prevalent Neurodegenerative Disorder: Mechanistic Insights, Emerging Targets and Drug Discovery Campaigns
inferred← citeshttps://doi.org/10.1002/syn.20642openalex-snapshot
The relationship between nicotinic receptors and cognitive functioning in healthy aging: An in vivo positron emission tomography (PET) study with 2‐[18F]fluoro‐A‐85380
inferred← citeshttps://doi.org/10.1002/trc2.12168openalex-snapshot
Prescribing cholinesterase inhibitors in mild cognitive impairment—Observations from the Alzheimer's Disease Neuroimaging Initiative
inferred← citeshttps://doi.org/10.1006/bbrc.1999.1561openalex-snapshot
Profound and Selective Loss of Catalytic TrkB Immunoreactivity in Alzheimer's Disease
inferred← citeshttps://doi.org/10.1006/exnr.2000.7397openalex-snapshot
On Neurodegenerative Diseases, Models, and Treatment Strategies: Lessons Learned and Lessons Forgotten a Generation Following the Cholinergic Hypothesis
inferred← citeshttps://doi.org/10.1006/exnr.2001.7700openalex-snapshot
Selective Antibody-Induced Cholinergic Cell and Synapse Loss Produce Sustained Hippocampal and Cortical Hypometabolism with Correlated Cognitive Deficits
inferred← citeshttps://doi.org/10.1007/978-0-387-46526-5_10openalex-snapshot
Links Between Amyloid and Tau Biology in Alzheimer’s Disease and Their Cholinergic Aspects
inferred← citeshttps://doi.org/10.1007/978-0-387-71522-3_1openalex-snapshot
Overview of the Alzheimer's Disease Pathology and Potential Therapeutic Targets
inferred← citeshttps://doi.org/10.1007/978-0-387-71522-3_5openalex-snapshot
Cholinergic Neurodegeneration in Alzheimer's Disease: Basis for Nerve Growth Factor Therapy
inferred← citeshttps://doi.org/10.1007/978-0-387-72076-0_42openalex-snapshot
Evidence That Amyloid Pathology Progresses in a Neurotransmitter-Specific Manner
inferred← citeshttps://doi.org/10.1007/978-1-349-05932-4_15openalex-snapshot
Transmitter Biochemistry of Huntington’s Disease
inferred← citeshttps://doi.org/10.1007/978-1-349-05932-4_17openalex-snapshot
Biogenic Amines and Related Enzymes in Normal Aging, Senile Dementia and Chronic Alcoholism
inferred← citeshttps://doi.org/10.1007/978-1-349-05932-4_18openalex-snapshot
Biochemical Changes in Alzheimer’s Disease in Relation to Histopathology, Clinical Findings and Pathogenesis
inferred← citeshttps://doi.org/10.1007/978-1-349-06870-8_8openalex-snapshot
Tetrahydrobiopterin metabolism, neurological disease and mental retardation
inferred← citeshttps://doi.org/10.1007/978-1-349-12275-2_7openalex-snapshot
Changes of the Neuroendocrine System in Alzheimer-type Dementia
inferred← citeshttps://doi.org/10.1007/978-1-349-12664-4_31openalex-snapshot
Galanin in the primate CNS and dementing neurologic diseases
inferred← citeshttps://doi.org/10.1007/978-1-4419-7104-3openalex-snapshot
Neurochemical Mechanisms in Disease
inferred← citeshttps://doi.org/10.1007/978-1-4612-1302-4_14openalex-snapshot
Septal Lesions as a Model for Evaluating Potential Cognition Enhancers
inferred← citeshttps://doi.org/10.1007/978-1-4612-4604-6_10openalex-snapshot
Molecular Biology and Neurobiology of Choline Acetyltransferase
inferred← citeshttps://doi.org/10.1007/978-1-4612-5250-4_38openalex-snapshot
Virus Can Alter Cell Function Without Causing Cell Pathology: Disordered Function Leads to Imbalance of Homeostasis and Disease
inferred← citeshttps://doi.org/10.1007/978-1-4613-0513-2_46openalex-snapshot
Increased Blood Flow Augments CNS Axon Regeneration
inferred← citeshttps://doi.org/10.1007/978-1-4613-0933-8_1openalex-snapshot
Neuropathological and Neurochemical Aspects of Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-1-4613-0933-8_2openalex-snapshot
Basal Forebrain Cholinergic Neurons and Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-1-4613-0933-8_3openalex-snapshot
Neurochemical Studies in Dementia
inferred← citeshttps://doi.org/10.1007/978-1-4613-0933-8_4openalex-snapshot
Chemical Neuroanatomy of Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-1-4613-0933-8_7openalex-snapshot
The Cholinergic Hypothesis of Memory: A Review of Animal Experiments
inferred← citeshttps://doi.org/10.1007/978-1-4613-2179-8_3openalex-snapshot
Histopathology of the Basal Forebrain and its Targets in Alzheimer Dementia
inferred← citeshttps://doi.org/10.1007/978-1-4613-2179-8_38openalex-snapshot
Acetylcholinesterase activity and somatostatin-like immunoreactivity in Lumbar cerebrospinal fluid of demented patients
inferred← citeshttps://doi.org/10.1007/978-1-4613-2179-8_48openalex-snapshot
Reversal of Cerebral Metabolic Deficits in Rodent Models for Aging and Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-1-4613-2179-8_7openalex-snapshot
Cholinergic and Non-Cholinergic Neurotransmitter Hypotheses for Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-1-4613-2321-1_13openalex-snapshot
Brain Messenger RNA in Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-1-4613-2705-9_10openalex-snapshot
Recovery of Function in Senile Dementia of the Alzheimer Type
inferred← citeshttps://doi.org/10.1007/978-1-4613-2934-3_14openalex-snapshot
Brain Acetylcholine and Disorders of Memory
inferred← citeshttps://doi.org/10.1007/978-1-4613-2934-3_15openalex-snapshot
Carbohydrates and Acetylcholine Synthesis: Implications for Cognitive Disorders
inferred← citeshttps://doi.org/10.1007/978-1-4613-3991-5_20openalex-snapshot
Brain Monoamines, Monoamine Metabolites and Enzymes in Physiological Ageing and Senile Dementia
inferred← citeshttps://doi.org/10.1007/978-1-4613-9194-4_14openalex-snapshot
Advances in Biological Psychiatry
inferred← citeshttps://doi.org/10.1007/978-1-4615-0282-1_2openalex-snapshot
Cholinergic Plasticity and the Meaning of Death
inferred← citeshttps://doi.org/10.1007/978-1-4615-1857-0_1openalex-snapshot
Perspective of Neurochemistry in Neurological Disorders
inferred← citeshttps://doi.org/10.1007/978-1-4615-3420-4_3openalex-snapshot
Neural Transplantation and Recovery of Function: Animal Studies
inferred← citeshttps://doi.org/10.1007/978-1-4615-3432-7_21openalex-snapshot
Modulation of Frontal Cortical Acetylcholine Release by Benzodiazepine Receptor Ligands: Age-Dependent Effects and Behavioral Correlates
inferred← citeshttps://doi.org/10.1007/978-1-4615-3432-7_33openalex-snapshot
Cholinergic Phenotype of Septal Cell Lines
inferred← citeshttps://doi.org/10.1007/978-1-4615-5337-3_123openalex-snapshot
Current Neurotransmitter Strategies in AD Drug Development
inferred← citeshttps://doi.org/10.1007/978-1-4615-5337-3_64openalex-snapshot
The Rationale for Development of Cholinergic Therapies in ad
inferred← citeshttps://doi.org/10.1007/978-1-4615-5337-3_95openalex-snapshot
Molecular Mechanisms of AF64A Toxicity in the Cholinergic Neuron
inferred← citeshttps://doi.org/10.1007/978-1-4615-6414-0_12openalex-snapshot
Serotonin, Alzheimer’s Disease and Learning and Memory in Animals
inferred← citeshttps://doi.org/10.1007/978-1-4615-6414-0_9openalex-snapshot
Neurotransmitters in the Ageing Brain and Dementia
inferred← citeshttps://doi.org/10.1007/978-1-4615-6805-6_14openalex-snapshot
Animal Models of Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-1-4615-6805-6_29openalex-snapshot
Cholinergic Treatment of Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-1-4615-7255-8_17openalex-snapshot
Implantable Pumps to Deliver Drugs Directly into the CNS
inferred← citeshttps://doi.org/10.1007/978-1-4615-8149-9_47openalex-snapshot
Toward the Repair of Cortical Synapses in Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-1-4615-8149-9_61openalex-snapshot
The Centrally Cholinodeficient Animal as a Model of Alzheimer’s Disease (AD)
inferred← citeshttps://doi.org/10.1007/978-1-4615-9843-5_13openalex-snapshot
Serotonin Influences on Cholinergic Function: Possible Interactions in Learning and Memory
inferred← citeshttps://doi.org/10.1007/978-1-4615-9843-5_21openalex-snapshot
Cognition Enhancement Based on GABA-Cholinergic Interactions
inferred← citeshttps://doi.org/10.1007/978-1-4615-9843-5_3openalex-snapshot
Synaptic Organization of Basal Forebrain Cholinergic Projection Neurons
inferred← citeshttps://doi.org/10.1007/978-1-4684-0556-9_10openalex-snapshot
An Analysis of the Basal Forebrain Contribution to Learning and Memory
inferred← citeshttps://doi.org/10.1007/978-1-4684-0556-9_2openalex-snapshot
The Basal Forebrain Cholinergic System: An Evolving Concept in the Neurobiology of the Forebrain
inferred← citeshttps://doi.org/10.1007/978-1-4684-1218-5_11openalex-snapshot
Cholinergic Neuropsychopharmacology and Neuropathology of Dementias
inferred← citeshttps://doi.org/10.1007/978-1-4684-3096-7_54openalex-snapshot
Cholinergic Systems and Disorders of Carbohydrate Catabolism
inferred← citeshttps://doi.org/10.1007/978-1-4684-4178-9_2openalex-snapshot
Cellular Mechanisms of Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-1-4684-4208-3_11openalex-snapshot
Human Brain Postmortem Studies of Neurotransmitters and Related Markers
inferred← citeshttps://doi.org/10.1007/978-1-4684-5003-3_43openalex-snapshot
Anatomical and Behavioral Studies Following Lesions on the Basal Magnocellular Nucleus in the Rat
inferred← citeshttps://doi.org/10.1007/978-1-4684-5003-3_52openalex-snapshot
Functions of Nucleus Basalis Magnocellularis Input to the Neocortex: A Reconstitution Analysis Using Intracerebral Transplantation
inferred← citeshttps://doi.org/10.1007/978-1-4684-5194-8_11openalex-snapshot
Reduced Acetylcholine Synthesis in Alzheimer’s Disease is a Clinically Relevant Change
inferred← citeshttps://doi.org/10.1007/978-1-4684-5194-8_21openalex-snapshot
Basal Forebrain Cholinergic Systems in Primate Brain: Anatomical Organization and Role in the Pathology of Aging and Dementia
inferred← citeshttps://doi.org/10.1007/978-1-4684-5194-8_27openalex-snapshot
Human Red Blood Cell Choline in Aging and Senile Dementia: Effects of Precursor Therapy
inferred← citeshttps://doi.org/10.1007/978-1-4684-5266-2_1openalex-snapshot
Distribution of Cholinergic Neurons in Human Brain
inferred← citeshttps://doi.org/10.1007/978-1-4684-5266-2_22openalex-snapshot
Role of Acetylcholine in the Cerebral Cortex
inferred← citeshttps://doi.org/10.1007/978-1-4684-5502-1_11openalex-snapshot
Somatostatin and Neuropeptide Y: Coexistence in the Hippocampus and Alterations in Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-1-4684-5727-8_21openalex-snapshot
Transneuronal Neurochemical and Neuropathological Changes Induced by Nucleus Basalis Lesions: A Possible Degenerative Mechanism in Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-1-4684-5727-8_29openalex-snapshot
Postmortem Stability of RNA Metabolism in Human Brain: Studies of the Nondemented Control and Alzheimer’s Disease Cases
inferred← citeshttps://doi.org/10.1007/978-1-4684-5844-2_109openalex-snapshot
Subtypes of Nicotinic Receptors in Human Cortex: Selective Changes in Alzheimer Disease
inferred← citeshttps://doi.org/10.1007/978-1-4684-5844-2_110openalex-snapshot
Alterations in Muscarinic Cholinergic Receptors and the Second Messenger System in the Cerebral Cortex in Alzheimer-Type Dementia
inferred← citeshttps://doi.org/10.1007/978-1-4684-5844-2_27openalex-snapshot
Abnormal Phospholipid Metabolism in Neurodegenerative Diseases: Elevations in Glycerophosphocholine and Glycerophospho-Ethanolamine Levels in Brain of Alzheimer’s Disease But Not in Down Syndrome Patients
inferred← citeshttps://doi.org/10.1007/978-1-4684-5844-2_88openalex-snapshot
Cholinergic Systems in Alzheimer’s Disease, Parkinson’s Disease and Progressive Supranuclear Palsy
inferred← citeshttps://doi.org/10.1007/978-1-4684-5844-2_89openalex-snapshot
Neurochemical Aspects of Parkinson’s Disease and the Dementing Brain Disorders: Relation to Brain Ageing
inferred← citeshttps://doi.org/10.1007/978-1-4684-5847-3_68openalex-snapshot
Behavioral and Neurochemical Effects of AF64A in Young and Old Fischer 344 Male Rats
inferred← citeshttps://doi.org/10.1007/978-1-4684-5847-3_70openalex-snapshot
Rationale for the Planned Clinical Trials with Nerve Growth Factor in Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-1-4684-5847-3_76openalex-snapshot
The Effect of Chinese Herbal Medicine TJ-23 (Toki-Syakuyaku-San) on the Choline Acetyltransferase Activity in the Cortex of Rat
inferred← citeshttps://doi.org/10.1007/978-1-4684-8329-1_28openalex-snapshot
Morphological Backgrounds of Pathochemical Studies in Major Psychoses
inferred← citeshttps://doi.org/10.1007/978-1-4684-8643-8_91openalex-snapshot
Cholinomimetic Agents and Human Memory: Preliminary Observations in Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-1-4684-8893-7_1openalex-snapshot
Age-Dependent Changes in Central Dopaminergic and Other Monoaminergic Systems
inferred← citeshttps://doi.org/10.1007/978-1-4757-0797-7_23openalex-snapshot
Biochemistry of Senile Dementia
inferred← citeshttps://doi.org/10.1007/978-1-4757-5971-6_5openalex-snapshot
Effects of Hypoxia on Muscarinic Cholinergic and Benzodiazepine/γ — Aminobutyric Acid Receptors in the Rat Brain
inferred← citeshttps://doi.org/10.1007/978-1-4757-9145-7_63openalex-snapshot
Alzheimer Disease: Major Neurotransmitter Deficits. Can they be Corrected?
inferred← citeshttps://doi.org/10.1007/978-1-4757-9145-7_87openalex-snapshot
Neurotrophic Factor Therapy of Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-1-4899-1483-5_21openalex-snapshot
Therapy of Alzheimer’s Dementia
inferred← citeshttps://doi.org/10.1007/978-1-4899-1681-5_10openalex-snapshot
Biochemistry and Pathophysiology of the Molecular Forms of Cholinesterases
inferred← citeshttps://doi.org/10.1007/978-1-4899-5199-1_29openalex-snapshot
GABA in Huntington’s Chorea, Parkinsonism and Schizophrenia
inferred← citeshttps://doi.org/10.1007/978-1-4899-6738-1_25openalex-snapshot
Swedish Experiences of THA Therapy in Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-1-4899-6738-1_31openalex-snapshot
Heptylphysostigmine — Novel Acetylcholinesterase Inhibitor: Biochemical and Behavioral Pharmacology
inferred← citeshttps://doi.org/10.1007/978-1-4899-6738-1_32openalex-snapshot
Clinical and Preclinical Studies with Huperzine
inferred← citeshttps://doi.org/10.1007/978-1-4899-6738-1_47openalex-snapshot
The Effects of Nerve Growth Factor on the Central Nervous System of the Adult Primate
inferred← citeshttps://doi.org/10.1007/978-1-59259-465-8_3openalex-snapshot
Organization of Neuropeptide Y Neurons in the Mammalian Central Nervous System
inferred← citeshttps://doi.org/10.1007/978-1-59259-691-1_1openalex-snapshot
The Cholinergic Hypothesis a Generation Later
inferred← citeshttps://doi.org/10.1007/978-1-59259-896-0_6openalex-snapshot
Exploring the Role of Acetylcholine in Primate Cognition Using Me20.4 IgG-Saporin
inferred← citeshttps://doi.org/10.1007/978-1-84628-440-3_16openalex-snapshot
Mouse Models of Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-3-030-42825-9_139-1openalex-snapshot
Cognitive Enhancers and Treatments for Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-3-030-51366-5_139openalex-snapshot
Cognitive Enhancers and Treatments for Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-3-030-74046-7_9openalex-snapshot
Rita Levi-Montalcini, NGF Metabolism in Health and in the Alzheimer’s Pathology
inferred← citeshttps://doi.org/10.1007/978-3-030-96221-0_23openalex-snapshot
Acupuncture and Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-3-031-69188-1_7openalex-snapshot
Alzheimer’s Disease from Modeling to Mechanism Research
inferred← citeshttps://doi.org/10.1007/978-3-032-31497-0_8openalex-snapshot
Alzheimer’s Disease: Progress in Biomarkers, Diagnostics and Therapies
inferred← citeshttps://doi.org/10.1007/978-3-319-26206-2_2openalex-snapshot
The Practical Pharmacology of Donepezil
showing the first 200 of 1257 · page through all 1257
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.